Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Recenti Prog Med. 2012 Dec;103(12):559-63. doi: 10.1701/1206.13356.

[Cardiorenal syndrome: the role of new biochemical markers].

[Article in Italian]

Author information

  • 1Universita di Palermo, Italy. federicavernuccio@gmail.com

Abstract

Cardiorenal syndrome is a pathophysiological heart and kidney disorder, in which acute or chronic dysfunction of one organ induces a damage in the other. It's a syndrome more and more often encountered in clinical practice and this implies the need to recognize the syndrome through biochemical markers with a good sensitivity and specificity, since its earliest stages in order to optimize therapy. In addition to widely validated biomarkers, such as BNP, pro BNP, creatinine, GFR and cystatin C, other promising molecules are available, like NGAL (neutrophil gelatinase-associated lipocalin, KIM-1 (kidney injury molecule-1), MCP-1 (monocyte chemotactic peptide), Netrin-1, interleuchin 18 and NAG (N-acetyl-β-glucosa-minidase). The role of these emerging biomarkers is still not completely clarified: hence the need of new clinical trials.

PMID:
23258238
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Il Pensiero Scientifico Editore
    Loading ...
    Write to the Help Desk